These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33313060)

  • 61. Albumin downregulates Klotho in tubular cells.
    Fernandez-Fernandez B; Izquierdo MC; Valiño-Rivas L; Nastou D; Sanz AB; Ortiz A; Sanchez-Niño MD
    Nephrol Dial Transplant; 2018 Oct; 33(10):1712-1722. PubMed ID: 29425318
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
    Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
    Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biomarkers determining cardiovascular risk in patients with kidney disease.
    Siasos G; Tousoulis D; Michalea S; Oikonomou E; Kolia C; Kioufis S; Synetos A; Vlasis K; Papavassiliou AG; Stefanadis C
    Curr Med Chem; 2012; 19(16):2555-71. PubMed ID: 22489717
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry.
    Luczak M; Formanowicz D; Marczak Ł; Pawliczak E; Wanic-Kossowska M; Figlerowicz M; Stobiecki M
    J Transl Med; 2015 Jan; 13():20. PubMed ID: 25622820
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling.
    Zhou L; Li Y; Zhou D; Tan RJ; Liu Y
    J Am Soc Nephrol; 2013 Apr; 24(5):771-85. PubMed ID: 23559584
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiovascular disease and its relationship with chronic kidney disease.
    Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
    Liu QF; Ye JM; Yu LX; He AL; Sun Q; He DW; Li SS
    J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Klotho and vascular calcification].
    Matsui M; Saito Y
    Clin Calcium; 2016 Aug; 26(8):1157-64. PubMed ID: 27461499
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mineral metabolism and cardiovascular disease in CKD.
    Fujii H; Joki N
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A short story of Klotho and FGF23: a deuce of dark side or the savior?
    Ersoy FF
    Int Urol Nephrol; 2014 Mar; 46(3):577-81. PubMed ID: 24057685
    [TBL] [Abstract][Full Text] [Related]  

  • 71. α-klotho and anemia in patients with chronic kidney disease patients: A new perspective.
    Xu Y; Peng H; Ke B
    Exp Ther Med; 2017 Dec; 14(6):5691-5695. PubMed ID: 29250136
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2-5D].
    Milovanova LY; Lysenko Kozlovskaya LV; Milovanova SY; Taranova MV; Kozlov VV; Reshetnikov VA; Lebedeva MV; Androsova TV; Zubacheva DO; Chebotareva NV
    Ter Arkh; 2020 Jul; 92(6):37-45. PubMed ID: 33346491
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Klotho restrain RIG-1/NF-κB signaling activation and monocyte inflammatory factor release under uremic condition.
    He T; Xiong J; Huang Y; Zheng C; Liu Y; Bi X; Liu C; Han W; Yang K; Xiao T; Xu X; Yu Y; Huang Y; Zhang J; Zhang B; Zhao J
    Life Sci; 2019 Aug; 231():116570. PubMed ID: 31207307
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Klotho as a Therapeutic Target during the Development of Renal Fibrosis.
    Doi S; Masaki T
    Contrib Nephrol; 2017; 189():178-183. PubMed ID: 27951565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
    Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J
    J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease.
    Chen J; Zhang X; Zhang H; Liu T; Zhang H; Teng J; Ji J; Ding X
    Int J Biol Sci; 2016; 12(10):1236-1246. PubMed ID: 27766038
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
    Milovanov YS; Mukhin NA; Kozlovskaya LV; Milovanova SY; Markina MM
    Ter Arkh; 2016; 88(6):21-25. PubMed ID: 27296257
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cardiovascular disease in children with chronic kidney disease.
    Mitsnefes MM
    J Am Soc Nephrol; 2012 Apr; 23(4):578-85. PubMed ID: 22383696
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
    de Seigneux S; Martin PY
    Pharmacol Res; 2016 Apr; 106():87-91. PubMed ID: 26900884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.